Indaba Capital Management, L.P. insider trades: Tabula Rasa HealthCare (TRHC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Indaba Capital Management, L.P. reports to the SEC





Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 25, 2022 | TRHC | ↑ Buy | 59,262 | $4.28 | $254K | Indirect | Jul 27, 2022 (2d) |
| Jul 22, 2022 | TRHC | ↑ Buy | 1,293,292 | $3.97 | $5.1M | Indirect | Jul 25, 2022 (3d) |
| Mar 28, 2022 | BNFT | ↑ Buy | 142,047 | $12.63 | $1.8M | Indirect | Mar 28, 2022 (0d) |
| Mar 23, 2022 | BNFT | ↑ Buy | 300,136 | $11.39 | $3.4M | Indirect | Mar 23, 2022 (0d) |
| May 29, 2015 | UPIP | ↓ Sell | 5,500,000 | $0.88 | $4.9M | Indirect | Jun 1, 2015 (3d) |
| Feb 3, 2014 | UPIP | ↑ Buy | 245,000 | $1.65 | $403K | Indirect | Feb 4, 2014 (1d) |
| Feb 3, 2014 | UPIP | ↑ Buy | 245,000 | $1.65 | $403K | Direct | Feb 4, 2014 (1d) |
| Dec 10, 2012 | NEYYF | ↑ Buy | 1,385,000 | $0.10 | $140K | Direct | Dec 10, 2012 (0d) |
| Dec 10, 2012 | NEYYF | ↑ Buy | 95,000 | $0.10 | $10K | See foonote | Dec 10, 2012 (0d) |
| Dec 7, 2012 | NEYYF | ↑ Buy | 1,290,000 | $0.10 | $130K | Indirect | Dec 10, 2012 (3d) |
| Jan 4, 2012 | GKK | ↓ Sell | 26,000 | $24.78 | $644K | Indirect | Jan 6, 2012 (2d) |
| Jan 4, 2012 | GKK | ↓ Sell | 26,000 | $24.78 | $644K | Direct | Jan 6, 2012 (2d) |
| Sep 23, 2011 | GKK | ↑ Buy | 108,200 | $3.01 | $326K | Indirect | Sep 26, 2011 (3d) |
| Sep 23, 2011 | GKK | ↑ Buy | 108,200 | $3.01 | $326K | Direct | Sep 26, 2011 (3d) |
| Sep 6, 2011 | GKK | ↑ Buy | 133,000 | $3.13 | $417K | Indirect | Sep 7, 2011 (1d) |
| Sep 6, 2011 | GKK | ↑ Buy | 133,000 | $3.13 | $417K | Direct | Sep 7, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Indaba Capital Management, L.P.'s insider trades
Indaba Capital Management, L.P. is a director at Tabula Rasa HealthCare (TRHC). Since Sep 6, 2011, it has reported 13 open-market purchases worth $13.2M and 3 sales worth $6.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include grants and awards (5 filings), shares returned to the company (3 filings), option exercises (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TRHC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.